China's Pharmaceutical Market Suffers Growing Pains
China's Pharmaceutical Market Suffers Growing Pains
Attachment: China API 0721
BEIJING--July 30, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--China's pharmaceutical companies produced 2.734 million metric tons of active pharmaceutical ingredients (API) in 2020, according to China's National Bureau of Statistics, a 2.7% increase from 2019. But China's API market is facing an excess of manufacturing capacity, monopolized production and a tight environmental policy that has resulted in a few compulsory shutdowns.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market
- BMS Investing $400 Million in Dublin Sterile Drug Expansion